Geriatric emergency medication safety recommendations: Difference between revisions
No edit summary |
No edit summary |
||
| Line 68: | Line 68: | ||
*Examples: [[zolpidem]] (Ambien), [[zaleplon]] (Sonata), [[eszopiclone]] (Lunesta) | *Examples: [[zolpidem]] (Ambien), [[zaleplon]] (Sonata), [[eszopiclone]] (Lunesta) | ||
| | | | ||
*Insomnia | *Insomnia | ||
*Anxiety | **Use [[melatonin]], [[ramelteon]], [[doxepin]] (<=3 mg) | ||
*Anxiety | |||
**Use [[mirtazapine]], [[buspirone]], serotonin–norepinephrine reuptake inhibitor (serotonin and norepinephrine reuptake inhibitor, eg, [[duloxetine]], [[venlafaxine]], [[desvenlafaxine]]) | |||
| | | | ||
|- | |- | ||
Revision as of 21:57, 20 May 2026
High-Risk Medications to Avoid for Geriatric Patients at ED Discharge[1]
| High-Risk Therapeutic Class (AVOID) | Alternative Options (Preferred) | Valid Exceptions^ (Use with Caution) |
|---|---|---|
Barbiturates
|
|
|
| Benzodiazepines |
|
|
First-generation antihistamines
|
|
|
| Metoclopramide |
|
|
First-generation antipsychotics
|
|
|
Nonbenzodiazepines (Z-drugs)
|
|
|
| Skeletal muscle relaxants |
|
|
| Sulfonylureas | Metformin, long-acting insulin (eg, glargine). |
^Indications for use where high-risk medication benefit may outweigh risks.
See Also
- ↑ Skains, et al. Geriatric Emergency Medication Safety Recommendations (GEMS-Rx). Annals of Emergency Medicine. September 2024. 84(3):274-284. https://doi.org/10.1016/j.annemergmed.2024.01.033
